Kirill V Rosen

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Epidermal Growth Factor Receptor

Breast Cancer Cells

Top Venues

Breast cancer research : BCR

Cell death & disease

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Sandhya Chipurupalli, Peijia Jiang, Xiaoyang Liu, Julia Linhares Santos, Paola Marcato, Kirill V Rosen
Three-dimensional growth sensitizes breast cancer cells to treatment with ferroptosis-promoting drugs. Cell death & disease 14 (9) (2023)
Xiaoyang Liu, Sandhya Chipurupalli, Peijia Jiang, Mahtab Tavasoli, Byong Hoon Yoo, Michael McPhee, Sina Mazinani, Giulio Francia, Robert S Kerbel, Kirill V Rosen
ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth. Cell death & disease 13 (8) (2022)
Alexi Surette, Byong Hoon Yoo, Tallal Younis, Kara Matheson, Tarek Rameh, Jaime Snowdon, Gillian Bethune, Kirill V Rosen
Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies. Breast cancer research and treatment 187 (3) (2021)
Arik Drucker, Byong Hoon Yoo, Iman Aftab Khan, Dongsic Choi, Laura Montermini, Xiaoyang Liu, Sanja Jovanovic, Tallal Younis, Kirill V Rosen
Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity. Breast cancer research : BCR 22 (1) (2020)
Iman Aftab Khan, Byong Hoon Yoo, Michael McPhee, Olivier Masson, Alexi Surette, Kelly Dakin-Hache, Tallal Younis, Gillian Bethune, Kirill V Rosen
ErbB2-driven downregulation of the transcription factor Irf6 in breast epithelial cells is required for their 3D growth. Breast cancer research : BCR 20 (1) (2018)